Increased platelet activation demonstrated by elevated CD36 and P-selectin expression in one-year post-recovered COVID-19 patients

Samuel S.Y. Wang, M.D.
Tan Tock Seng Hospital
Singapore City, Singapore

Increased thrombotic burden is caused by hypercoagulability and platelet hyperactivity which are characteristics of COVID-19 infection. Wang, M.D., presents information from examination of platelet activation profiles of patients up to 16 months post-COVID-19 infection. The findings from this study provide early evidence given their elevated CD62P and CD36 levels for hyperactivated platelet phenotype in recovered COVID-19 patients.

Previous Article Prevalence and risk factors for thromboembolism in women with sickle cell disease during pregnancy
Next Article Suzanne Dubois: How a mother of a VTE patient now advocates for VTE research and knowledge through CanVECTOR